It has been documented that IL-6 signaling plays a critical role in a variety of cancers, as demonstrated by the elevated expression levels of IL-6 mRNA and protein in colorectal, prostate, breast, ovarian, pancreatic, and cervical cancer [149]. This evidence concerns the gene IL6 and cervical carcinoma.